BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12173980)

  • 1. Valproate and valproate-analogues: potent tools to fight against cancer.
    Blaheta RA; Nau H; Michaelis M; Cinatl J
    Curr Med Chem; 2002 Aug; 9(15):1417-33. PubMed ID: 12173980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate: past, present, and future.
    Johannessen CU; Johannessen SI
    CNS Drug Rev; 2003; 9(2):199-216. PubMed ID: 12847559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: evaluation of the teratogenic effects of its amide derivatives in NMRI mice.
    Okada A; Onishi Y; Yagen B; Shimshoni JA; Kaufmann D; Bialer M; Fujiwara M
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):610-21. PubMed ID: 18671279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of valproate derivatives II. Antiepileptic efficacy in relation to chemical structures of valproate sugar esters.
    Redecker C; Altrup U; Hoppe D; Hense T; Kreier A; Rabe A; Düsing R; Speckmann EJ
    Neuropharmacology; 2000 Jan; 39(2):267-81. PubMed ID: 10670422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?
    Isoherranen N; Yagen B; Bialer M
    Curr Opin Neurol; 2003 Apr; 16(2):203-11. PubMed ID: 12644750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic Acid: second generation.
    Bialer M; Yagen B
    Neurotherapeutics; 2007 Jan; 4(1):130-7. PubMed ID: 17199028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of sodium valproate and its metabolites (5-OH-VPA and 4-OH-VPA) on electroconvulsions in rats.
    Sobaniec W; Sobaniec-Lotowska M
    Mater Med Pol; 1994; 26(1):29-32. PubMed ID: 7808038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of VPA on bone: From clinical studies to cell cultures-The molecular mechanisms revisited.
    Pitetzis DA; Spilioti MG; Yovos JG; Yavropoulou MP
    Seizure; 2017 May; 48():36-43. PubMed ID: 28391043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor mechanisms of valproate: a novel role for an old drug.
    Blaheta RA; Cinatl J
    Med Res Rev; 2002 Sep; 22(5):492-511. PubMed ID: 12210556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
    Lampen A; Göttlicher M; Nau H
    ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of valproic acid administration during pregnancy on postnatal development of cerebellar cortex and the possible protective role of folic acid.
    Shona SI; Rizk AA; El Sadik AO; Emam HY; Ali EN
    Folia Morphol (Warsz); 2018; 77(2):201-209. PubMed ID: 29064543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile.
    Mishra MK; Kukal S; Paul PR; Bora S; Singh A; Kukreti S; Saso L; Muthusamy K; Hasija Y; Kukreti R
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice.
    Okada A; Noyori H; Yagen B; Shimshoni JA; Bialer M; Fujiwara M
    Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy.
    Löscher W; Nau H; Marescaux C; Vergnes M
    Eur J Pharmacol; 1984 Mar; 99(2-3):211-8. PubMed ID: 6428923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological activity of two derivatives of the amide of valproic acid.
    Bechar E; Astroug H
    Arch Pharm (Weinheim); 1997 Oct; 330(9-10):273-6. PubMed ID: 9396384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect.
    Bojic U; Elmazar MM; Hauck RS; Nau H
    Chem Res Toxicol; 1996; 9(5):866-70. PubMed ID: 8828922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological evaluation of various metabolites and analogues of valproic acid. Anticonvulsant and toxic potencies in mice.
    Löscher W; Nau H
    Neuropharmacology; 1985 May; 24(5):427-35. PubMed ID: 3927183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teratology of valproic acid: an updated review of the possible mediating mechanisms.
    Ponzano A; Tiboni GM
    Minerva Ginecol; 2018 Jun; 70(3):303-322. PubMed ID: 28398022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel valproic acid derivatives with potent differentiation-inducing activity in myeloid leukemia cells.
    Deubzer H; Busche B; Rönndahl G; Eikel D; Michaelis M; Cinatl J; Schulze S; Nau H; Witt O
    Leuk Res; 2006 Sep; 30(9):1167-75. PubMed ID: 16510182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo radiosensitivity is increased in non-cancer patients taking valproate.
    Stritzelberger J; Lainer J; Gollwitzer S; Graf W; Jost T; Lang JD; Mueller TM; Schwab S; Fietkau R; Hamer HM; Distel L
    BMC Neurol; 2020 Oct; 20(1):390. PubMed ID: 33099323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.